Further supporting our results, Ajijola et al. have found that NPY immunoreactivity is decreased, but its mRNA expression did not change in the stellate ganglia of heart failure patients compared to healthy controls, suggesting increased release of NPY from the stellate ganglia [49]. Here, NPY is linked to heart failure.